Invega Side Effect Report#9994856 Lacrimation Increased, Eye Pruritus |
This is a report of a 43-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: bipolar disorder, who was treated with Invega Sustenna (dosage: NA, start time: Feb 05, 2014), combined with: NA. and developed a serious reaction and side effect(s): Lacrimation Increased, Eye Pruritus after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Invega Sustenna treatment in female patients, resulting in Lacrimation Increased side effect.
|
Invega Side Effect Report#9994808 Investigation, Injection Site Nodule, Treatment Noncompliance |
This report suggests a potential Invega Sustenna Investigation side effect(s) that can have serious consequences. A 20-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Invega Sustenna (dosage: NA) starting NS. After starting Invega Sustenna the patient began experiencing various side effects, including: Investigation, Injection Site Nodule, Treatment NoncomplianceAdditional drugs used concurrently: NA.The patient was hospitalized. Although Invega Sustenna demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Investigation, may still occur.
|
Invega Side Effect Report#9994807 Chest Discomfort, Nervousness, Muscle Rigidity, Anxiety, Blood Pressure Increased, Injection Site Pain |
This Chest Discomfort problem was reported by a consumer or non-health professional from CN. A 35-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: schizophrenia. On 2013 this consumer started treatment with Invega Sustenna (dosage: NA). The following drugs were being taken at the same time: NA. When using Invega Sustenna, the patient experienced the following unwanted symptoms/side effects: Chest Discomfort, Nervousness, Muscle Rigidity, Anxiety, Blood Pressure Increased, Injection Site PainThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Chest Discomfort, may become evident only after a product is in use by the general population.
|
Invega Side Effect Report#9991988 Delusion, Treatment Noncompliance |
This Delusion side effect was reported by a health professional from US. A 32-year-old female patient (weight:NA) experienced the following symptoms/conditions: schizophrenia.The patient was prescribed Invega (drug dosage: NA), which was initiated on 201312. Concurrently used drugs: NA..After starting to take Invega the consumer reported adverse symptoms, such as: Delusion, Treatment NoncomplianceThese side effects may potentially be related to Invega.
|
Invega Side Effect Report#9991987 Depression |
This is a report of a 19-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: NA, who was treated with Invega (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Depression after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Invega treatment in male patients, resulting in Depression side effect.
|
Invega Side Effect Report#9991757 Injection Site Nodule |
This report suggests a potential Invega Sustenna Injection Site Nodule side effect(s) that can have serious consequences. A 32-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: schizophrenia and used Invega Sustenna (dosage: NA) starting 2014. After starting Invega Sustenna the patient began experiencing various side effects, including: Injection Site NoduleAdditional drugs used concurrently: NA. Although Invega Sustenna demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Injection Site Nodule, may still occur.
|
Invega Side Effect Report#9980763 Akathisia |
This Akathisia problem was reported by a health professional from US. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: schizophrenia. On 201402 this consumer started treatment with Invega Sustenna (dosage: NA). The following drugs were being taken at the same time: NA. When using Invega Sustenna, the patient experienced the following unwanted symptoms/side effects: AkathisiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Akathisia, may become evident only after a product is in use by the general population.
|
Invega Side Effect Report#9969838 Adverse Event |
This Adverse Event side effect was reported by a consumer or non-health professional from US. A male patient (weight:NA) experienced the following symptoms/conditions: schizophrenia.The patient was prescribed Invega (drug dosage: NA), which was initiated on 201312. Concurrently used drugs: NA..After starting to take Invega the consumer reported adverse symptoms, such as: Adverse EventThese side effects may potentially be related to Invega.
|
Invega Side Effect Report#9969836 Sedation, Mental Impairment |
This is a report of a male patient (weight: NA) from US, suffering from the following health symptoms/conditions: schizoaffective disorder, who was treated with Invega Sustenna (dosage: NA, start time: 201310), combined with: NA. and developed a serious reaction and side effect(s): Sedation, Mental Impairment after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Invega Sustenna treatment in male patients, resulting in Sedation side effect. The patient was hospitalized.
|
Invega Side Effect Report#9969835 Pollakiuria, Restless Legs Syndrome, Dyskinesia |
This report suggests a potential Invega Sustenna Pollakiuria side effect(s) that can have serious consequences. A male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: schizophrenia and used Invega Sustenna (dosage: NA) starting 2012. After starting Invega Sustenna the patient began experiencing various side effects, including: Pollakiuria, Restless Legs Syndrome, DyskinesiaAdditional drugs used concurrently: NA. Although Invega Sustenna demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pollakiuria, may still occur.
|
Invega Side Effect Report#9963988 Gynaecomastia |
This Gynaecomastia problem was reported by a health professional from US. A 29-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Invega Sustenna (dosage: NA). The following drugs were being taken at the same time: NA. When using Invega Sustenna, the patient experienced the following unwanted symptoms/side effects: GynaecomastiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Gynaecomastia, may become evident only after a product is in use by the general population.
|
Invega Side Effect Report#9960710 Condition Aggravated |
This Condition Aggravated side effect was reported by a physician from US. A 50-year-old male patient (weight:NA) experienced the following symptoms/conditions: schizoaffective disorder.The patient was prescribed Invega Sustenna (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Invega Sustenna the consumer reported adverse symptoms, such as: Condition AggravatedThese side effects may potentially be related to Invega Sustenna.
|
Invega Side Effect Report#9938602 Hyponatraemia |
This is a report of a 54-year-old male patient (weight: NA) from JP, suffering from the following health symptoms/conditions: NA, who was treated with Invega (dosage: NA, start time: Dec 11, 2013), combined with: - Nexium
- Seroquel
- Barnetil
- Mucosta
- Akineton
- Magmitt
and developed a serious reaction and side effect(s): Hyponatraemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Invega treatment in male patients, resulting in Hyponatraemia side effect. The patient was hospitalized. |
Invega Side Effect Report#9938097 Gynaecomastia |
This report suggests a potential Invega Sustenna Gynaecomastia side effect(s) that can have serious consequences. A 27-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Invega Sustenna (dosage: NA) starting NS. After starting Invega Sustenna the patient began experiencing various side effects, including: GynaecomastiaAdditional drugs used concurrently: NA. Although Invega Sustenna demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Gynaecomastia, may still occur.
|
Invega Side Effect Report#9938089 Neuroleptic Malignant Syndrome, Aggression, Confusional State, Cogwheel Rigidity, Tremor, Hyperhidrosis |
This Neuroleptic Malignant Syndrome problem was reported by a physician from CH. A 43-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: schizophrenia, paranoid type. On Aug 12, 2013 this consumer started treatment with Invega (dosage: NA). The following drugs were being taken at the same time: - Clozapine
- Clozapine
- Clozapine
- Clozapine
- Clopixol
- Clopixol
- Temesta
- Depakin
When using Invega, the patient experienced the following unwanted symptoms/side effects: Neuroleptic Malignant Syndrome, Aggression, Confusional State, Cogwheel Rigidity, Tremor, HyperhidrosisThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Neuroleptic Malignant Syndrome, may become evident only after a product is in use by the general population. |
Invega Side Effect Report#9931710 Sedation, Accidental Overdose |
This Sedation side effect was reported by a health professional from US. A 32-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Invega Sustenna (drug dosage: Two Days In A Row), which was initiated on NS. Concurrently used drugs: NA..After starting to take Invega Sustenna the consumer reported adverse symptoms, such as: Sedation, Accidental OverdoseThese side effects may potentially be related to Invega Sustenna.
|
Invega Side Effect Report#9925397 Paranoia, Adverse Event |
This is a report of a female patient (weight: NA) from US, suffering from the following health symptoms/conditions: schizoaffective disorder, who was treated with Invega Sustenna (dosage: NA, start time: 2013), combined with: NA. and developed a serious reaction and side effect(s): Paranoia, Adverse Event after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Invega Sustenna treatment in female patients, resulting in Paranoia side effect.
|
Invega Side Effect Report#9921402 Incorrect Dose Administered |
This report suggests a potential Invega Sustenna Incorrect Dose Administered side effect(s) that can have serious consequences. A 53-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: schizophrenia and used Invega Sustenna (dosage: NA) starting Jan 31, 2014. After starting Invega Sustenna the patient began experiencing various side effects, including: Incorrect Dose AdministeredAdditional drugs used concurrently: - Cogentin
- Wellbutrin
- Klonopin
- Haldol
- Ativan
- Risperidone
- Altace
Although Invega Sustenna demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Incorrect Dose Administered, may still occur. |
Invega Side Effect Report#9919218 Treatment Noncompliance, Product Outer Packaging Issue |
This Treatment Noncompliance problem was reported by a health professional from US. A 23-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: schizophrenia. On 201303 this consumer started treatment with Invega Sustenna (dosage: NA). The following drugs were being taken at the same time: NA. When using Invega Sustenna, the patient experienced the following unwanted symptoms/side effects: Treatment Noncompliance, Product Outer Packaging IssueAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Treatment Noncompliance, may become evident only after a product is in use by the general population.
|
Invega Side Effect Report#9919217 Galactorrhoea, Blood Prolactin Increased |
This Galactorrhoea side effect was reported by a health professional from US. A 29-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Invega Sustenna (drug dosage: NA), which was initiated on 2012. Concurrently used drugs: NA..After starting to take Invega Sustenna the consumer reported adverse symptoms, such as: Galactorrhoea, Blood Prolactin IncreasedThese side effects may potentially be related to Invega Sustenna.
|
Invega Side Effect Report#9919215 Eye Disorder, Dysarthria, Dyspnoea, Dyskinesia, Extrapyramidal Disorder, Vision Blurred, Off Label Use |
This is a report of a 14-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: affective disorder, who was treated with Invega Sustenna (dosage: Day 1 Dose, start time: Jan 24, 2014), combined with: NA. and developed a serious reaction and side effect(s): Eye Disorder, Dysarthria, Dyspnoea, Dyskinesia, Extrapyramidal Disorder, Vision Blurred, Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Invega Sustenna treatment in female patients, resulting in Eye Disorder side effect.
|
Invega Side Effect Report#9919211 Weight Increased |
This report suggests a potential Invega Sustenna Weight Increased side effect(s) that can have serious consequences. A 30-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: schizophrenia and used Invega Sustenna (dosage: NA) starting NS. After starting Invega Sustenna the patient began experiencing various side effects, including: Weight IncreasedAdditional drugs used concurrently: NA. Although Invega Sustenna demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Weight Increased, may still occur.
|
Invega Side Effect Report#9919210 Injection Site Pain |
This Injection Site Pain problem was reported by a pharmacist from US. A 20-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: schizophrenia. On 2013 this consumer started treatment with Invega Sustenna (dosage: NA). The following drugs were being taken at the same time: NA. When using Invega Sustenna, the patient experienced the following unwanted symptoms/side effects: Injection Site PainAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Injection Site Pain, may become evident only after a product is in use by the general population.
|
Invega Side Effect Report#9919209 Off Label Use |
This Off Label Use side effect was reported by a consumer or non-health professional from US. A 41-year-old male patient (weight:NA) experienced the following symptoms/conditions: schizoaffective disorder.The patient was prescribed Invega Sustenna (drug dosage: In Between (tricep And Bicep)), which was initiated on 2013. Concurrently used drugs: NA..After starting to take Invega Sustenna the consumer reported adverse symptoms, such as: Off Label UseThese side effects may potentially be related to Invega Sustenna.
|
Invega Side Effect Report#9916258 Psychotic Disorder, Memory Impairment |
This is a report of a 22-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: schizophrenia, who was treated with Invega Sustenna (dosage: NA, start time: 201312), combined with: NA. and developed a serious reaction and side effect(s): Psychotic Disorder, Memory Impairment after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Invega Sustenna treatment in male patients, resulting in Psychotic Disorder side effect.
|